Healing happens in connection
Yessodot · a moment of integrationIsrael
Yessodot unites Israel's leading clinicians, researchers, and healing centers to bring psychedelic-assisted care to those conventional medicine has left behind.
The crisis
In the wake of October 7 and ongoing military operations, Israel faces a quiet mental health emergency.
Healing happens in connection
Yessodot · a moment of integrationOur approach
Yessodot integrates clinical rigor, therapeutic depth, and community support.
The world's first Phase 1 and Phase 2a ibogaine clinical trials.
Whole-person care at the Yessodot clinic.
Ensuring that treatment reaches those who need it most.
The science
Ibogaine is not a fringe treatment.
Documented reductions in PTSD.
Completed a 40-person observational study.
$100 million public-private commitment.
Ibogaine is a naturally occurring alkaloid.
The evidence
In the RESET-VET observational program.
Track 1 preliminary Outcome · Sheba Medical Center · May 2026
RESET-VET: symptom trajectories. Group means across all five measures.
Our partners
Yessodot brings together Israel's foremost medical institutions.
Home to the Sagol Neuroscience Center.
Clinical ibogaine-assisted therapy research.
An integrative psychedelic clinic.
The Team
Yessodot is led by clinicians, researchers, and advocates.
Arik Metzer is a Tel Aviv-based psychotherapist specializing in trauma and PTSD, following a senior leadership career in high-tech. He leads Yessodot's clinical work, shaping its trauma treatment programs and evidence-informed care for veterans.
Boaz Wachtel is a medicalization activist and co-author of the Ibogaine Treatment Manual, with decades of experience advancing patient-centered psychedelic care. He brings advocacy expertise and institutional knowledge to Yessodot's mission of expanding veterans' access to ibogaine treatment.
David Lankri is a medicinal chemist and neuropharmacologist at Columbia University, where he synthesizes novel iboga alkaloids and studies how they act on the brain. He provides Yessodot with scientific expertise on the chemistry and pharmacology of ibogaine.
Marissa Feinberg is a strategic communications leader specializing in emerging therapies. She leads Yessodot's media strategy and program oversight, building awareness and support for veterans' access to ibogaine treatment.
Yael Levy is an operations professional with a background in therapeutic practice. She manages Yessodot's administration, logistics, and participant coordination, creating a structured and supportive experience for veterans in the program.
Give
Support the world's first clinical trials of ibogaine for IDF veterans.